OXiGENE (OXGN) Announces Presentation At The ROTH Conference On March 11, 2014
3/7/2014 9:24:32 AM
SOUTH SAN FRANCISCO, Calif., March 7, 2014 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced that Peter Langecker, M.D., PhD., President and Chief Executive Officer, will provide a corporate overview at the ROTH Capital Partners 26th Annual Growth Stock Conference on Tuesday, March 11, 2014 at 12:00 pm PT at The Ritz Carlton Hotel in Dana Point California.
Help employers find you! Check out all the jobs and post your resume.
comments powered by